VANCOUVER, B.C. – Disordered sleep in mid- to late life is associated with an increased risk for future cognitive impairment and may alter the dynamics of the Alzheimer’s disease–associated protein amyloid-beta, according to several studies.
Treating childhood sleep apnea normalized levels of neuronal metabolites in the brain and improved attention at other measures of cognitive function, explains Dr. Ann Halbower.
Editors: Claudio Bassetti, Zoran Dogas, Philippe Peigneux Publisher: European Sleep Research Society (ESRS) Regensburg, 2014 ISBN: 9781119038931 The Sleep Medicine Textbook provides comprehensive, all-in-one educational material (550 pages) structured around the Catalogue of knowledge and skills for sleep medicine (Penzel et al. 2014, Journal of Sleep Research). Written by experts in the field and published […]
Administration of zolpidem in hospital patients is associated with a significantly higher risk of falls according to a Mayo Clinic study published Nov. 19 in the Journal of Hospital Medicine.
F. Angelico, M. Del Ben, M. Fabiani, Department of Internal Medicine and Medical Specialities, Sapienza University, Rome, Italy
The promise of shorter time to sleep, longer sleep duration, and fewer side effects associated with the experimental sleep drug suvorexant has sleep medicine clinicians and their patients eagerly anticipating the approval of the first-in-class agent.
BOSTON – Treatment with continuous positive airway pressure does double duty in patients with obstructive sleep apnea by improving their mood while promoting restful sleep, Dr. Charles Bae reported at the annual meeting of the Associated Professional Sleep Societies.
Consistently short sleep duration not only leaves otherwise healthy individuals tired, it also increases their risk of developing stroke, a study has shown.
Excessive daytime sleepiness in patients with obstructive sleep apnea remains a common and often debilitating problem, despite optimal use of continuous positive airway pressure treatment, according to Dr. Janine R.E. Vintch.
Proposed DSM-5 criteria for sleep-wake disorders include dropping the DSM-IV’s “primary insomnia” diagnosis in favor of “insomnia disorder,” and decreasing use of the term “not otherwise specified.” The changes reflect a move away from the need to make causal attribution between coexisting disorders and also the overall DSM-5 shift toward more data-driven diagnostic criteria, said […]
PHOENIX – Sleep medicine doctors need to get ahead of the curve on home sleep apnea testing or risk being put out of business, according to Dr. Charles W. Atwood Jr., director of the Sleep Disorders Program at the Veterans Affairs Pittsburgh Healthcare System.
Sleep-disordered breathing in infancy and early childhood increases the likelihood of problematic behavior in later childhood, findings from a large, population-based, longitudinal study suggest.
When patients’ sleep cycles are out of synch with the rest of the world, melatonin and light therapy can help. But for night owls – people who fall asleep at 5 a.m. and awake at noon, for instance – it’s important to use a low dose of melatonin, 0.5-1 mg, and it should be given […]
A low-dose sublingual formulation of zolpidem tartrate is the first agent to be approved to treat insomnia characterized by middle-of-the-night waking followed by difficulty returning to sleep, the Food and Drug Administration announced Nov. 23.
‘On-Off’ Switches Shed Light on Brain Disorders : Narcolepsy, Cataplexy, and REM sleep Behavior Disorder linked to errant ‘flip-flop’ Mechanisms.
A series of “on-off” switches regulates sleep, clarifying many of the mechanisms underlying narcolepsy, cataplexy, and REM sleep behavior disorder, according to Dr. Clifford B. Saper.